FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2129304079> ?p ?o ?g. }

• W2129304079 endingPage "455" @default.
• W2129304079 startingPage "449" @default.
• W2129304079 abstract "Heterologous prime-boost vaccination has been shown to be an efficient way of inducing T cell responses in animals and in humans. We have used three vaccine vectors, naked DNA, modified vaccinia virus Ankara (MVA), and attenuated fowlpox strain, FP9, for prime-boost vaccination approaches against Plasmodium falciparum malaria in humans. In this study, we characterize, using two types of ELISPOT assays and FACS analysis, cell-mediated immune responses induced by different prime-boost combinations where all vectors encode a multiepitope string fused to the pre-erythrocytic Ag thrombospondin-related adhesion protein. We show that these different vectors need to be used in a specific order for an optimal ex vivo IFN-gamma response. From the different combinations, DNA priming followed by MVA boosting and FP9 priming followed by MVA boosting were most immunogenic and in both cases the IFN-gamma response was of broad specificity and cross-reactive against two P. falciparum strains (3D7 and T9/96). Immunization with all three vectors showed no improvement over optimal two vector regimes. Strong ex vivo IFN-gamma responses peaked 1 wk after the booster dose, but cultured ELISPOT assays revealed longer-lasting T cell memory responses for at least 6 mo. In the DNA-primed vaccinees the IFN-gamma response was mainly due to CD4(+) T cells, whereas in the FP9-primed vaccinees it was mainly due to CD4-dependent CD8(+) T cells. This difference may be of importance for the protective efficacy of these vaccination approaches against various diseases." @default.
• W2129304079 created "2016-06-24" @default.
• W2129304079 creator A5037138357 @default.
• W2129304079 creator A5057673896 @default.
• W2129304079 creator A5057807377 @default.
• W2129304079 creator A5059924108 @default.
• W2129304079 creator A5078693210 @default.
• W2129304079 creator A5078990203 @default.
• W2129304079 creator A5079914158 @default.
• W2129304079 date "2005-01-01" @default.
• W2129304079 modified "2023-10-14" @default.
• W2129304079 title "Differential Immunogenicity of Various Heterologous Prime-Boost Vaccine Regimens Using DNA and Viral Vectors in Healthy Volunteers" @default.
• W2129304079 cites W1489581869 @default.
• W2129304079 cites W1553933269 @default.
• W2129304079 cites W1766024448 @default.
• W2129304079 cites W1965810830 @default.
• W2129304079 cites W1983918344 @default.
• W2129304079 cites W1986059049 @default.
• W2129304079 cites W2007599113 @default.
• W2129304079 cites W2038062991 @default.
• W2129304079 cites W2048666922 @default.
• W2129304079 cites W2053801470 @default.
• W2129304079 cites W2062096354 @default.
• W2129304079 cites W2070426326 @default.
• W2129304079 cites W2081139134 @default.
• W2129304079 cites W2081825634 @default.
• W2129304079 cites W2093218237 @default.
• W2129304079 cites W2093619015 @default.
• W2129304079 cites W2095135796 @default.
• W2129304079 cites W2103663071 @default.
• W2129304079 cites W2105798507 @default.
• W2129304079 cites W2131748930 @default.
• W2129304079 cites W2134502530 @default.
• W2129304079 cites W2145447612 @default.
• W2129304079 cites W3020957148 @default.
• W2129304079 doi "https://doi.org/10.4049/jimmunol.174.1.449" @default.
• W2129304079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15611270" @default.
• W2129304079 hasPublicationYear "2005" @default.
• W2129304079 type Work @default.
• W2129304079 sameAs 2129304079 @default.
• W2129304079 citedByCount "150" @default.
• W2129304079 countsByYear W21293040792012 @default.
• W2129304079 countsByYear W21293040792013 @default.
• W2129304079 countsByYear W21293040792014 @default.
• W2129304079 countsByYear W21293040792015 @default.
• W2129304079 countsByYear W21293040792016 @default.
• W2129304079 countsByYear W21293040792017 @default.
• W2129304079 countsByYear W21293040792018 @default.
• W2129304079 countsByYear W21293040792019 @default.
• W2129304079 countsByYear W21293040792020 @default.
• W2129304079 countsByYear W21293040792021 @default.
• W2129304079 countsByYear W21293040792022 @default.
• W2129304079 countsByYear W21293040792023 @default.
• W2129304079 crossrefType "journal-article" @default.
• W2129304079 hasAuthorship W2129304079A5037138357 @default.
• W2129304079 hasAuthorship W2129304079A5057673896 @default.
• W2129304079 hasAuthorship W2129304079A5057807377 @default.
• W2129304079 hasAuthorship W2129304079A5059924108 @default.
• W2129304079 hasAuthorship W2129304079A5078693210 @default.
• W2129304079 hasAuthorship W2129304079A5078990203 @default.
• W2129304079 hasAuthorship W2129304079A5079914158 @default.
• W2129304079 hasBestOaLocation W21293040791 @default.
• W2129304079 hasConcept C100701293 @default.
• W2129304079 hasConcept C104317684 @default.
• W2129304079 hasConcept C159047783 @default.
• W2129304079 hasConcept C167508917 @default.
• W2129304079 hasConcept C203014093 @default.
• W2129304079 hasConcept C207001950 @default.
• W2129304079 hasConcept C22070199 @default.
• W2129304079 hasConcept C26291073 @default.
• W2129304079 hasConcept C2776090121 @default.
• W2129304079 hasConcept C2777760223 @default.
• W2129304079 hasConcept C2779053233 @default.
• W2129304079 hasConcept C2780115692 @default.
• W2129304079 hasConcept C2780801004 @default.
• W2129304079 hasConcept C2780868878 @default.
• W2129304079 hasConcept C2781356689 @default.
• W2129304079 hasConcept C32470452 @default.
• W2129304079 hasConcept C40767141 @default.
• W2129304079 hasConcept C54355233 @default.
• W2129304079 hasConcept C59822182 @default.
• W2129304079 hasConcept C81444415 @default.
• W2129304079 hasConcept C86803240 @default.
• W2129304079 hasConcept C8891405 @default.
• W2129304079 hasConceptScore W2129304079C100701293 @default.
• W2129304079 hasConceptScore W2129304079C104317684 @default.
• W2129304079 hasConceptScore W2129304079C159047783 @default.
• W2129304079 hasConceptScore W2129304079C167508917 @default.
• W2129304079 hasConceptScore W2129304079C203014093 @default.
• W2129304079 hasConceptScore W2129304079C207001950 @default.
• W2129304079 hasConceptScore W2129304079C22070199 @default.
• W2129304079 hasConceptScore W2129304079C26291073 @default.
• W2129304079 hasConceptScore W2129304079C2776090121 @default.
• W2129304079 hasConceptScore W2129304079C2777760223 @default.
• W2129304079 hasConceptScore W2129304079C2779053233 @default.
• W2129304079 hasConceptScore W2129304079C2780115692 @default.
• W2129304079 hasConceptScore W2129304079C2780801004 @default.
• W2129304079 hasConceptScore W2129304079C2780868878 @default.

• next